The number of patients with end stage renal disease (ESRD) is increasing faster than the number of renal transplantations performed per year worldwide. Of the primary diseases leading to ESRD, diabetic nephropathy is the leading cause. The purpose of the present study is to investigate the association of HLA with the primary diseases leading to ESRD in Turkish patients. A total of 3230 individuals comprising 587 ESRD patients and 2643 healthy controls were enrolled into the study. Class I HLA-A, -B typing was performed by CDC method, while class II HLA-DRB1 typing was performed by low resolution PCR-SSP. We found a significant negative association between almost all A locus antigens and primary disease groups classified as chronic glomerulo...
The expression of major histocompatibility antigens class II (MHC II) in renal diseases has been stu...
The role of human leukocyte antigen (HLA) class II polymorphisms in the pathogenesis and progression...
<p>N = number of individuals, ESRD = End Stage Renal Disease, control = healthy donors, F = al...
Chronic renal failure (CRF) leads in the majority of instances to end stage renal disease (ESRD) req...
Chronic renal failure (CRF) leads in the majority of instances to end stage renal disease (ESRD) req...
Chronic renal failure (CRF) leads in the majority of instances to end-stage renal disease (ESRD) req...
Since the first association between HLA and diseases of native kidneys was described almost 50 years...
Exposure to human leukocyte antigens (HLA) via blood transfusions, pregnancies, and previous transpl...
Background: End-Stage Renal Disease (ESRD) is a worldwide public health problem. Currently, many gen...
End-Stage Renal Disease (ESRD) is a worldwide public health problem. Currently, many genome-wide ass...
The aim of this study was to investigate the human leukocyte antigen (HLA) profile of children with ...
BACKGROUND: End-Stage Renal Disease (ESRD) is a worldwide public health problem. Currently, many gen...
AIM: The research was conducted by genotyping two Human Leukocyte Antigen (HLA) gene classes. The ma...
<p>N = number of individuals, ESRD = End Stage Renal Disease, control = healthy donors, F = al...
Introduction. Of great interest are the studies on the role of human leucocyte antigens (HLA) in pat...
The expression of major histocompatibility antigens class II (MHC II) in renal diseases has been stu...
The role of human leukocyte antigen (HLA) class II polymorphisms in the pathogenesis and progression...
<p>N = number of individuals, ESRD = End Stage Renal Disease, control = healthy donors, F = al...
Chronic renal failure (CRF) leads in the majority of instances to end stage renal disease (ESRD) req...
Chronic renal failure (CRF) leads in the majority of instances to end stage renal disease (ESRD) req...
Chronic renal failure (CRF) leads in the majority of instances to end-stage renal disease (ESRD) req...
Since the first association between HLA and diseases of native kidneys was described almost 50 years...
Exposure to human leukocyte antigens (HLA) via blood transfusions, pregnancies, and previous transpl...
Background: End-Stage Renal Disease (ESRD) is a worldwide public health problem. Currently, many gen...
End-Stage Renal Disease (ESRD) is a worldwide public health problem. Currently, many genome-wide ass...
The aim of this study was to investigate the human leukocyte antigen (HLA) profile of children with ...
BACKGROUND: End-Stage Renal Disease (ESRD) is a worldwide public health problem. Currently, many gen...
AIM: The research was conducted by genotyping two Human Leukocyte Antigen (HLA) gene classes. The ma...
<p>N = number of individuals, ESRD = End Stage Renal Disease, control = healthy donors, F = al...
Introduction. Of great interest are the studies on the role of human leucocyte antigens (HLA) in pat...
The expression of major histocompatibility antigens class II (MHC II) in renal diseases has been stu...
The role of human leukocyte antigen (HLA) class II polymorphisms in the pathogenesis and progression...
<p>N = number of individuals, ESRD = End Stage Renal Disease, control = healthy donors, F = al...